These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 16299311)
1. Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease. Murphy TF; Brauer AL; Aebi C; Sethi S Infect Immun; 2005 Dec; 73(12):8161-6. PubMed ID: 16299311 [TBL] [Abstract][Full Text] [Related]
2. Human serum and mucosal antibody responses to outer membrane protein G1b of Moraxella catarrhalis in chronic obstructive pulmonary disease. Adlowitz DG; Kirkham C; Sethi S; Murphy TF FEMS Immunol Med Microbiol; 2006 Feb; 46(1):139-46. PubMed ID: 16420607 [TBL] [Abstract][Full Text] [Related]
3. Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease. Murphy TF; Brauer AL; Aebi C; Sethi S Infect Immun; 2005 Jun; 73(6):3471-8. PubMed ID: 15908376 [TBL] [Abstract][Full Text] [Related]
4. Mucosal immune response to specific outer membrane proteins of Moraxella catarrhalis in young children. Meier PS; Freiburghaus S; Martin A; Heiniger N; Troller R; Aebi C Pediatr Infect Dis J; 2003 Mar; 22(3):256-62. PubMed ID: 12634588 [TBL] [Abstract][Full Text] [Related]
5. Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Murphy TF; Brauer AL; Grant BJ; Sethi S Am J Respir Crit Care Med; 2005 Jul; 172(2):195-9. PubMed ID: 15805178 [TBL] [Abstract][Full Text] [Related]
6. Identification of domains of the Hag/MID surface protein recognized by systemic and mucosal antibodies in adults with chronic obstructive pulmonary disease following clearance of Moraxella catarrhalis. LaFontaine ER; Snipes LE; Bullard B; Brauer AL; Sethi S; Murphy TF Clin Vaccine Immunol; 2009 May; 16(5):653-9. PubMed ID: 19321697 [TBL] [Abstract][Full Text] [Related]
7. Systemic and mucosal antibody response to Moraxella catarrhalis after exacerbations of chronic obstructive pulmonary disease. Bakri F; Brauer AL; Sethi S; Murphy TF J Infect Dis; 2002 Mar; 185(5):632-40. PubMed ID: 11865420 [TBL] [Abstract][Full Text] [Related]
8. Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalis. Adlowitz DG; Sethi S; Cullen P; Adler B; Murphy TF Infect Immun; 2005 Oct; 73(10):6601-7. PubMed ID: 16177336 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the serological responses to Moraxella catarrhalis immunoglobulin D-binding outer membrane protein and the ubiquitous surface proteins A1 and A2. Tan TT; Christensen JJ; Dziegiel MH; Forsgren A; Riesbeck K Infect Immun; 2006 Nov; 74(11):6377-86. PubMed ID: 16966403 [TBL] [Abstract][Full Text] [Related]
10. Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection. Ruckdeschel EA; Kirkham C; Lesse AJ; Hu Z; Murphy TF Infect Immun; 2008 Apr; 76(4):1599-607. PubMed ID: 18227159 [TBL] [Abstract][Full Text] [Related]
11. Temporal development of the humoral immune response to surface antigens of Moraxella catarrhalis in young infants. Verhaegh SJ; de Vogel CP; Riesbeck K; Lafontaine ER; Murphy TF; Verbrugh HA; Jaddoe VW; Hofman A; Moll HA; van Belkum A; Hays JP Vaccine; 2011 Aug; 29(34):5603-10. PubMed ID: 21704103 [TBL] [Abstract][Full Text] [Related]
12. Moraxella catarrhalis-specific Th1 cells in BAL fluids of chronic obstructive pulmonary disease patients. Amedei A; Della Bella C; Niccolai E; Stanflin N; Benagiano M; Duranti R; Del Prete G; Murphy TF; D'Elios MM Int J Immunopathol Pharmacol; 2009; 22(4):979-90. PubMed ID: 20074461 [TBL] [Abstract][Full Text] [Related]
13. The role and regulation of Moraxella catarrhalis-induced human beta-defensin 3 expression in human pulmonary epithelial cells. Haarmann H; Steiner T; Schreiber F; Heinrich A; Zweigner J; N'Guessan PD; Slevogt H Biochem Biophys Res Commun; 2015 Nov; 467(1):46-52. PubMed ID: 26417692 [TBL] [Abstract][Full Text] [Related]
14. Cigarette smoke modulates PGE(2) and host defence against Moraxella catarrhalis infection in human airway epithelial cells. Zhang W; Case S; Bowler RP; Martin RJ; Jiang D; Chu HW Respirology; 2011 Apr; 16(3):508-16. PubMed ID: 21199162 [TBL] [Abstract][Full Text] [Related]
15. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529. Mason KW; Zhu D; Scheuer CA; McMichael JC; Zlotnick GW; Green BA Vaccine; 2004 Sep; 22(25-26):3449-56. PubMed ID: 15308371 [TBL] [Abstract][Full Text] [Related]
16. Serum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in children. Ren D; Almudevar AL; Murphy TF; Lafontaine ER; Campagnari AA; Luke-Marshall N; Casey JR; Pichichero ME Vaccine; 2015 Oct; 33(43):5809-5814. PubMed ID: 26392013 [TBL] [Abstract][Full Text] [Related]
17. The respiratory pathogen moraxella catarrhalis binds to laminin via ubiquitous surface proteins A1 and A2. Tan TT; Forsgren A; Riesbeck K J Infect Dis; 2006 Aug; 194(4):493-7. PubMed ID: 16845633 [TBL] [Abstract][Full Text] [Related]
18. Salivary antibodies directed against outer membrane proteins of Moraxella catarrhalis in healthy adults. Stutzmann Meier P; Heiniger N; Troller R; Aebi C Infect Immun; 2003 Dec; 71(12):6793-8. PubMed ID: 14638765 [TBL] [Abstract][Full Text] [Related]
19. Virulence factors of Moraxella catarrhalis outer membrane vesicles are major targets for cross-reactive antibodies and have adapted during evolution. Augustyniak D; Seredyński R; McClean S; Roszkowiak J; Roszniowski B; Smith DL; Drulis-Kawa Z; Mackiewicz P Sci Rep; 2018 Mar; 8(1):4955. PubMed ID: 29563531 [TBL] [Abstract][Full Text] [Related]